These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34112703)

  • 1. Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.
    Hashem MD; Hopkins RO; Colantuoni E; Dinglas VD; Sinha P; Aronson Friedman L; Morris PE; Jackson JC; Hough CL; Calfee CS; Needham DM
    Thorax; 2022 Jan; 77(1):22-30. PubMed ID: 34112703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.
    Dinglas VD; Hopkins RO; Wozniak AW; Hough CL; Morris PE; Jackson JC; Mendez-Tellez PA; Bienvenu OJ; Ely EW; Colantuoni E; Needham DM
    Thorax; 2016 May; 71(5):401-10. PubMed ID: 26936876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
    Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
    Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
    Calfee CS; Delucchi KL; Sinha P; Matthay MA; Hackett J; Shankar-Hari M; McDowell C; Laffey JG; O'Kane CM; McAuley DF;
    Lancet Respir Med; 2018 Sep; 6(9):691-698. PubMed ID: 30078618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study.
    Slim MA; van Amstel RBE; Bos LDJ; Cremer OL; ; Wiersinga WJ; van der Poll T; van Vught LA
    Crit Care; 2024 May; 28(1):151. PubMed ID: 38715131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials.
    Pienkos SM; Moore AR; Guan J; Levitt JE; Matthay MA; Baron RM; Conlon J; McAuley DF; O'Kane CM; Rogers AJ
    Crit Care; 2023 Mar; 27(1):126. PubMed ID: 36978134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
    Maddali MV; Churpek M; Pham T; Rezoagli E; Zhuo H; Zhao W; He J; Delucchi KL; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Laffey JG; Bellani G; Calfee CS; Sinha P;
    Lancet Respir Med; 2022 Apr; 10(4):367-377. PubMed ID: 35026177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subphenotypes in patients with acute respiratory distress syndrome treated with high-flow oxygen.
    Blot PL; Chousterman BG; Santafè M; Cartailler J; Pacheco A; Magret M; Masclans JR; Artigas A; Roca O; García-de-Acilu M
    Crit Care; 2023 Nov; 27(1):419. PubMed ID: 37915062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular subphenotypes in two cohorts of paediatric ARDS.
    Yehya N; Zinter MS; Thompson JM; Lim MJ; Hanudel MR; Alkhouli MF; Wong H; Alder MN; McKeone DJ; Halstead ES; Sinha P; Sapru A
    Thorax; 2024 Jan; 79(2):128-134. PubMed ID: 37813544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
    Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
    ; Truwit JD; Bernard GR; Steingrub J; Matthay MA; Liu KD; Albertson TE; Brower RG; Shanholtz C; Rock P; Douglas IS; deBoisblanc BP; Hough CL; Hite RD; Thompson BT
    N Engl J Med; 2014 Jun; 370(23):2191-200. PubMed ID: 24835849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.
    Sinha P; Kerchberger VE; Willmore A; Chambers J; Zhuo H; Abbott J; Jones C; Wickersham N; Wu N; Neyton L; Langelier CR; Mick E; He J; Jauregui A; Churpek MM; Gomez AD; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Delucchi KL; Liu KD; Russell JA; Matthay MA; Walley KR; Ware LB; Calfee CS
    Lancet Respir Med; 2023 Nov; 11(11):965-974. PubMed ID: 37633303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar Biomarker Profiles in Subphenotypes of the Acute Respiratory Distress Syndrome.
    Sathe NA; Morrell ED; Bhatraju PK; Fessler MB; Stapleton RD; Wurfel MM; Mikacenic C
    Crit Care Med; 2023 Jan; 51(1):e13-e18. PubMed ID: 36519995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.
    Sinha P; Delucchi KL; Chen Y; Zhuo H; Abbott J; Wang C; Wickersham N; McNeil JB; Jauregui A; Ke S; Vessel K; Gomez A; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Liu KD; Matthay MA; Ware LB; Calfee CS
    Thorax; 2022 Jan; 77(1):13-21. PubMed ID: 34253679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
    Moore AR; Pienkos SM; Sinha P; Guan J; O'Kane CM; Levitt JE; Wilson JG; Shankar-Hari M; Matthay MA; Calfee CS; Baron RM; McAuley DF; Rogers AJ
    Crit Care Med; 2023 Dec; 51(12):e269-e274. PubMed ID: 37695136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Outcomes, and Predictors of Subphenotypes of Acute Kidney Injury among Acute Respiratory Distress Syndrome Patients: A Prospective Observational Study.
    Todur P; Nileshwar A; Chaudhuri S; Srinivas T
    Indian J Crit Care Med; 2023 Oct; 27(10):724-731. PubMed ID: 37908431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
    Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
    Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.
    Bos LDJ; Sjoding M; Sinha P; Bhavani SV; Lyons PG; Bewley AF; Botta M; Tsonas AM; Serpa Neto A; Schultz MJ; Dickson RP; Paulus F;
    Lancet Respir Med; 2021 Dec; 9(12):1377-1386. PubMed ID: 34653374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.
    Needham DM; Colantuoni E; Dinglas VD; Hough CL; Wozniak AW; Jackson JC; Morris PE; Mendez-Tellez PA; Ely EW; Hopkins RO
    Lancet Respir Med; 2016 Mar; 4(3):203-12. PubMed ID: 26832963
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.